MARKET

CNTB

CNTB

Connect Biopharma Holdings Ltd
NASDAQ
1.080
0.000
0.00%
After Hours: 1.110 +0.03 +2.77% 19:48 09/28 EDT
OPEN
1.080
PREV CLOSE
1.080
HIGH
1.110
LOW
1.050
VOLUME
2.46M
TURNOVER
--
52 WEEK HIGH
3.820
52 WEEK LOW
1.050
MARKET CAP
68.01M
P/E (TTM)
-0.9029
1D
5D
1M
3M
1Y
5Y
1D
Connect Biopharma Is Maintained at Outperform by Oppenheimer
Dow Jones · 6d ago
Connect Biopharma Price Target Cut to $5.00/Share From $8.00 by Oppenheimer
Dow Jones · 6d ago
Oppenheimer Maintains Outperform on Connect Biopharma Hldgs, Lowers Price Target to $5
Benzinga · 6d ago
Connect Biopharma price target lowered to $5 from $8 at Oppenheimer
TipRanks · 6d ago
H.C. Wainwright Sticks to Its Buy Rating for Connect Biopharma Holdings (CNTB)
TipRanks · 09/21 17:56
Weekly Report: what happened at CNTB last week (0914-0918)?
Weekly Report · 09/21 10:24
Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead
NASDAQ · 09/18 14:44
Buy Rating Maintained on CNTB as Rademikibart Data Supports Upside; $7 Price Target Reiterated
TipRanks · 09/17 10:25
More
About CNTB
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.

Webull offers Connect Biopharma Holdings Ltd (ADR) stock information, including NASDAQ: CNTB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNTB stock methods without spending real money on the virtual paper trading platform.